Showing results (201-210 of 280) with videos related to

Sort By:
Pageof 28
Malaria Journal|March 18, 2025
Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infectionAndrea A Berry, Thomas L Richie, L W Preston Church, et al.
Nature Medicine|March 20, 2018
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite proteinJoshua Tan, Brandon K Sack, David Oyen, et al.
Human Vaccines|December 1, 2009
Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malariaStephen L Hoffman, Peter F Billingsley, Eric James, et al.
The American Journal of Tropical Medicine and Hygiene|November 15, 2012
Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoitesMeta Roestenberg, Else M Bijker, B Kim Lee Sim, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2024
Glycogen synthase kinase 3 activity enhances liver inflammation in MASHMireille Khoury, Qianqian Guo, Kunimaro Furuta, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 21, 2024
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant populationK Rajender Reddy, Ethan M Weinberg, Stevan A Gonzalez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2019
Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human InfectionJane Achan, Isaie J Reuling, Xi Zen Yap, et al.
The Lancet. Infectious Diseases|September 26, 2025
Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trialKirsten E Lyke, Andrea A Berry, Matthew B Laurens, et al.
NPJ Vaccines|December 22, 2017
Protection against inhalation anthrax by immunization with Salmonella enterica serovar Typhi Ty21a stably producing protective antigen of Bacillus anthracisB Kim Lee Sim, Minglin Li, Manuel Osorio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2018
Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2Jean Claude Dejon-Agobe, Ulysse Ateba-Ngoa, Albert Lalremruata, et al.
Pageof 28